BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jenike AE, Halushka MK. miR-21: a non-specific biomarker of all maladies. Biomark Res 2021;9:18. [PMID: 33712063 DOI: 10.1186/s40364-021-00272-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Malvandi AM, Rastegar-Moghaddam SH, Ebrahimzadeh-Bideskan S, Lombardi G, Ebrahimzadeh-Bideskan A, Mohammadipour A. Targeting miR-21 in spinal cord injuries: a game-changer? Mol Med 2022;28:118. [PMID: 36138359 DOI: 10.1186/s10020-022-00546-w] [Reference Citation Analysis]
2 Ostrycharz E, Hukowska-Szematowicz B. Micro-Players of Great Significance-Host microRNA Signature in Viral Infections in Humans and Animals. Int J Mol Sci 2022;23:10536. [PMID: 36142450 DOI: 10.3390/ijms231810536] [Reference Citation Analysis]
3 Zhang F, Gou Z, Zhou Y, Huang L, Shao C, Wang M, Wu C, Lu L. MicroRNA-21-5p agomir inhibits apoptosis of oligodendrocyte precursor cell and attenuates white matter injury in neonatal rats. Brain Res Bull 2022:S0361-9230(22)00207-6. [PMID: 35985609 DOI: 10.1016/j.brainresbull.2022.08.014] [Reference Citation Analysis]
4 He F, Lv X, Li X, Yao M, Li K, Deng Y. Fluorescent microspheres lateral flow assay integrated with Smartphone-based reader for multiple microRNAs detection. Microchemical Journal 2022;179:107551. [DOI: 10.1016/j.microc.2022.107551] [Reference Citation Analysis]
5 Horie K, Nanashima N, Yokoyama Y, Yoshioka H, Watanabe J. Exosomal MicroRNA as Biomarkers for Diagnosing or Monitoring the Progression of Ovarian Clear Cell Carcinoma: A Pilot Study. Molecules 2022;27:3953. [PMID: 35745075 DOI: 10.3390/molecules27123953] [Reference Citation Analysis]
6 Reinhold AK, Krug SM, Salvador E, Sauer RS, Karl-Schöller F, Malcangio M, Sommer C, Rittner HL. MicroRNA-21-5p functions via RECK/MMP9 as a proalgesic regulator of the blood nerve barrier in nerve injury. Ann N Y Acad Sci 2022. [PMID: 35716075 DOI: 10.1111/nyas.14816] [Reference Citation Analysis]
7 Adewuyi JO, Patel R, Abbasciano R, McCann GP, Murphy G, Woźniak MJ, Singh A. A systematic review of micro-RNAs in aortic stenosis and cardiac fibrosis. Clin Transl Sci 2022. [PMID: 35579611 DOI: 10.1111/cts.13303] [Reference Citation Analysis]
8 Khan AA, Gupta V, Mahapatra NR. Key regulatory miRNAs in lipid homeostasis: implications for cardiometabolic diseases and development of novel therapeutics. Drug Discov Today 2022:S1359-6446(22)00190-8. [PMID: 35550438 DOI: 10.1016/j.drudis.2022.05.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Petroušková P, Hudáková N, Maloveská M, Humeník F, Cizkova D. Non-Exosomal and Exosome-Derived miRNAs as Promising Biomarkers in Canine Mammary Cancer. Life 2022;12:524. [DOI: 10.3390/life12040524] [Reference Citation Analysis]
10 Germena G, Zelarayán LC, Hinkel R. Cellular Chitchatting: Exploring the Role of Exosomes as Cardiovascular Risk Factors. Front Cell Dev Biol 2022;10:860005. [DOI: 10.3389/fcell.2022.860005] [Reference Citation Analysis]
11 Arun RP, Cahill HF, Marcato P. Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention. Biomedicines 2022;10:651. [DOI: 10.3390/biomedicines10030651] [Reference Citation Analysis]
12 Grieco GE, Besharat ZM, Licata G, Fignani D, Brusco N, Nigi L, Formichi C, Po A, Sabato C, Dardano A, Natali A, Dotta F, Sebastiani G, Ferretti E. Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside. Translational Research 2022. [DOI: 10.1016/j.trsl.2022.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Jorgensen BG, Ro S. MicroRNAs and 'Sponging' Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets. Int J Mol Sci 2022;23:2166. [PMID: 35216281 DOI: 10.3390/ijms23042166] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Solakoglu Ö, Steinbach B, Götz W, Heydecke G, Schwarzenbach H. Characterization of circulating molecules and activities in plasma of patients after allogeneic and autologous intraoral bone grafting procedures: a prospective randomized controlled clinical trial in humans. BMC Oral Health 2022;22. [DOI: 10.1186/s12903-021-02036-7] [Reference Citation Analysis]
15 Høye E, Fromm B, Böttger PHM, Domanska D, Torgunrud A, Lund-andersen C, Abrahamsen TW, Fretland Å, Dagenborg VJ, Lorenz S, Edwin B, Hovig E, Flatmark K. A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer. NAR Cancer 2022;4:zcab051. [DOI: 10.1093/narcan/zcab051] [Reference Citation Analysis]
16 Asa TA, Ravi Kumara GS, Seo YJ. Highly sensitive, selective, and rapid detection of miRNA-21 using an RCA/G-quadruplex/QnDESA probing system. Anal Methods 2021. [PMID: 34918721 DOI: 10.1039/d1ay01696b] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chiou P, Ohms S, Board PG, Dahlstrom JE, Rangasamy D, Casarotto MG. The Antiviral Drug Efavirenz in Breast Cancer Stem Cell Therapy. Cancers 2021;13:6232. [DOI: 10.3390/cancers13246232] [Reference Citation Analysis]
18 Wang G, Duan P, Liu F, Wei Z. Long non-coding RNA CASC7 suppresses malignant behaviors of breast cancer by regulating miR-21-5p/FASLG axis. Bioengineered 2021;12:11555-66. [PMID: 34889164 DOI: 10.1080/21655979.2021.2010372] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
19 Fontanella RA, Scisciola L, Rizzo MR, Surina S, Sardu C, Marfella R, Paolisso G, Barbieri M. Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism? Front Cardiovasc Med 2021;8:768026. [PMID: 34869683 DOI: 10.3389/fcvm.2021.768026] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
20 Bizzarri AR, Cannistraro S. Direct Interaction of miRNA and circRNA with the Oncosuppressor p53: An Intriguing Perspective in Cancer Research. Cancers (Basel) 2021;13:6108. [PMID: 34885216 DOI: 10.3390/cancers13236108] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Surina S, Fontanella RA, Scisciola L, Marfella R, Paolisso G, Barbieri M. miR-21 in Human Cardiomyopathies. Front Cardiovasc Med 2021;8:767064. [PMID: 34778418 DOI: 10.3389/fcvm.2021.767064] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
22 Correia de Sousa M, Calo N, Sobolewski C, Gjorgjieva M, Clément S, Maeder C, Dolicka D, Fournier M, Vinet L, Montet X, Dufour JF, Humar B, Negro F, Sempoux C, Foti M. Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis. Cancers (Basel) 2021;13:4983. [PMID: 34638467 DOI: 10.3390/cancers13194983] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
23 Biener M, Giannitsis E, Thum T, Bär C, Stoyanov KM, Salbach C, de Gonzalo-Calvo D, Frey N, Mueller-Hennessen M. Prognostic value of circulating microRNAs compared to high-sensitivity troponin T in patients presenting with suspected acute coronary syndrome to the emergency department. Clin Biochem 2021:S0009-9120(21)00250-2. [PMID: 34571048 DOI: 10.1016/j.clinbiochem.2021.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Schofield AL, Brown JP, Brown J, Wilczynska A, Bell C, Glaab WE, Hackl M, Howell L, Lee S, Dear JW, Remes M, Reeves P, Zhang E, Allmer J, Norris A, Falciani F, Takeshita LY, Seyed Forootan S, Sutton R, Park BK, Goldring C. Systems analysis of miRNA biomarkers to inform drug safety. Arch Toxicol 2021;95:3475-95. [PMID: 34510227 DOI: 10.1007/s00204-021-03150-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Jacquet K, Vidal-Cruchez O, Rezzonico R, Nicolini VJ, Mograbi B, Hofman P, Vassaux G, Mari B, Brest P. New technologies for improved relevance in miRNA research. Trends Genet 2021;37:1060-3. [PMID: 34474931 DOI: 10.1016/j.tig.2021.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Olivieri F, Prattichizzo F, Giuliani A, Matacchione G, Rippo MR, Sabbatinelli J, Bonafè M. miR-21 and miR-146a: The microRNAs of inflammaging and age-related diseases. Ageing Res Rev 2021;70:101374. [PMID: 34082077 DOI: 10.1016/j.arr.2021.101374] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 26.0] [Reference Citation Analysis]
27 Mariani M, Castagna C, Boccia S, Pastorino R. The Prognostic Role of Micro-RNAs in Head and Neck Cancers: An Umbrella Review. J Pers Med 2021;11:821. [PMID: 34442465 DOI: 10.3390/jpm11080821] [Reference Citation Analysis]
28 Boštjančič E, Večerić-Haler Ž, Kojc N. The Role of Immune-Related miRNAs in the Pathology of Kidney Transplantation. Biomolecules 2021;11:1198. [PMID: 34439863 DOI: 10.3390/biom11081198] [Reference Citation Analysis]
29 Li X, Zhang D, Gan X, Liu P, Zheng Q, Yang T, Tian G, Ding S, Yan Y. A Cascade Signal Amplification Based on Dynamic DNA Nanodevices and CRISPR/Cas12a Trans-cleavage for Highly Sensitive MicroRNA Sensing. ACS Synth Biol 2021;10:1481-9. [PMID: 34011151 DOI: 10.1021/acssynbio.1c00064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Leonetti A, Capula M, Minari R, Mazzaschi G, Gregori A, El Hassouni B, Papini F, Bordi P, Verzè M, Avan A, Tiseo M, Giovannetti E. Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs. Cells 2021;10:1520. [PMID: 34208765 DOI: 10.3390/cells10061520] [Cited by in F6Publishing: 1] [Reference Citation Analysis]